Utah Valley Pediatrics strives to keep parents up to date on the latest health topics and advisories. Our newsletter covers medicine changes and news, pediatric news, seasonal and age specific topics and what's new at Utah Valley Pediatrics.
Archives
November 2007
Vol. 1 Issue 1
Medicine Changes
and News
Cough and Cold Medication Targeted to Children Under Two Years of Age Pulled From Shelves
Pacifiers Help Reduce Risk of SIDS
Pediatric News
Seasonal and Age Specific
The Importance of Hand Washing
What's New
at UVP
Utah Valley Pediatrics Builds Upon Commitment to Quality Care Through Involvement With UPIQ
Utah Valley Pediatrics Opens an Office in Payson
Contacts
Kevin Moffitt
Administrator
801-373-8930
Katie Jenkins
Manager
801-373-8930
Quick Links
New Immunizations
In the last year, three new vaccinations were introduced to protect children from disease. These include the Gardasil vaccine (Human Papillomavirus vaccine), the RotaTeq vaccine (prevents severe rotavirus), and the Menactra vaccine (protects against bacterial meningitis).
Gardasil is a new vaccine approved by the FDA to prevent cervical cancer in females ages 9 to 26. It is a vaccine against the Human Papillomavirus (HPV), a sexually transmitted disease that causes genital warts, abnormal Pap tests and cervical cancer. Gardasil provides protection against four types of HPV that most commonly cause cervical cancer and genital warts. The Centers for Disease Control and Prevention recommend the HPV vaccine for all 11- and 12-year-old girls (and those who are older who have not already received the vaccine). Gardasil is given in a three-dose series over six months.
RotaTeq is an oral vaccine that has been shown to prevent 98 to 100 percent of severe rotavirus gastroenteritis in clinical trials. Rotavirus is a contagious infection often spread from person to person through fecal-oral transmission. It may cause diarrhea, vomiting, fever and dehydration and is a leading cause of severe diarrhea in infants and young children worldwide. Most children are infected before they are two years old. In the U.S., rotavirus causes an estimated 55,000 hospitalizations each year for infants and young children who become severely dehydrated. RotaTeq is the only vaccine licensed in the U.S. that effectively prevents rotavirus. The vaccine is administered in three doses at two, four and six months of age.
Menactra is a new meningococcal vaccine that is expected to offer better protection against meningitis over a longer period of time, an improvement over the previous meningococcal vaccine available since the 1970s. Meningococcal bacteria are the leading cause of bacterial meningitis in children 2 to 18 years old and can lead to outbreaks and epidemics, and can also cause a serious blood infection called meningococcemia. The CDC recommends the vaccine for children ages 11 and 12 years old. It is administered in one dose.
For more information:
Gardasil - http://www.cdc.gov/std/hpv/STDFact-HPV-vaccine.htm
RotaTeq - http://www.fda.gov/cber/products/rotamer020306qa.htm
Menactra - http://pediatrics.about.com/od/immunizations/a/05_menactra.htm
Add Us to Your Safe List
Commonly used email filters may accidentally filter Utah Valley Pediatric e-mails from your inbox. To prevent this from happening, please add emails ending with @uvpediatrics.com to your address book to continue receiving this newsletter as well as other helpful customer service communications from Utah Valley Pediatrics. Thank you.
Unsubscribe
You are currently subscribed to receive our e-mail newsletters. If you no longer want to receive our e-mail newsletters - Click here to unsubscribe and we will promptly remove you from our mailing list.
Privacy
Utah Valley Pediatrics respects your privacy and will never sell your email address to a third party. Read our Privacy Policy.